Mentions
Extended reach
Total likes
Video views
AI synopsis
Various discussions highlight the potential benefits of lowering the screening age to 40, with phrases like, "reducing the age limit for screening could reduce breast cancer mortality" reiterating the study's significance. Additionally, statements like, "25% reduction in breast cancer mortality in 40-49yo" showcase the data's effectiveness, while overall positive language like "could save lives" enhances the tone of urgency and optimism regarding faster adoption of the findings.
The majority of discussions express strong support for the findings that advocate for earlier screenings, indicating a consensus on the importance of the research.
There is a high level of curiosity and relevance about the implications of starting mammographic screening at an earlier age, as reflected in the frequency of discussions.
While many posts reference the publication, fewer delve into detailed methodologies or implications, suggesting moderate engagement.
Users overwhelmingly believe that the study's conclusions could significantly influence breast cancer screening guidelines, reflecting a strong conviction regarding its importance.
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/Z7XkFndPWP
25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/vRIbaJdmxt @CanadaSBI @CARadiologists
Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in countries like Mexico where the age presentation is younger than other countries. @BreastCaupdates @ProfAMThompson @Icro_Meattini https://t.co/W24kRDg3n6 https://t.co/0mvvU3vH8A
Estudio Randomizado demuestra que mamografía desde 40 años salva vidas. A no descuidarse! @yomujer @TheLancetOncol Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. S W Duffy.
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial ▪️Mortality reduction ▪️No overdiagnosis added ▪️ Absence of increase in risk of death from other causes https://t.co/xvsKmmOva4
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/XfVVrWHUQM
Welcome to our Journal Club Session 1 video, where we discuss a critical topic in women's health: Does early age screening reduce breast cancer mortality? We delve into the UK Age Trial's findings, revealing significant…
Do you work in the breast imaging industry of healthcare? These videos explain the important roles and standards that breast imaging facilities uphold to retain FDA certifications. Learn about the impact of mammographic…
RT @Dr_Ivanoncologo: Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in co…
RT @Dr_Ivanoncologo: Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in co…
RT @Dr_Ivanoncologo: Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in co…
RT @Dr_Ivanoncologo: Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in co…
RT @Dr_Ivanoncologo: Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in co…
RT @Dr_Ivanoncologo: Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in co…
Reducing the age limit for screening from 50 to 40 years could reduce breast cancer mortality. This is important in countries like Mexico where the age presentation is younger than other countries. @BreastCaupdates @ProfAMThompson @Icro_Meattini https://t.co/W24kRDg3n6 https://t.co/0mvvU3vH8A
EvidenceAlerts | Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. https://t.co/hrW7enV4f8
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/JVr2hBSoXa
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/UzTxQsRgT8
RT @tripdatabase: New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of…
RT @tripdatabase: New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of…
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/J5Nddd1tzC
RT @TripPrimaryCare: New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results…
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/UzTxQsRgT8
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/UzTxQsRgT8
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/J5Nddd1tzC
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/Y5rZEW3Exk
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/UzTxQszFuy
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/J5Nddd1tzC
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): RCT https://t.co/xhUbMDrgaP Yearly mammography before age 50 years, commencing at age 40 or 41 years, was associated with a relative reduction in breast cancer mortality
New2Trip: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of randomised, controlled trial https://t.co/UzTxQsRgT8
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/FX0tbZUG7L
乳がん検診におけるマンモは50代より、40代からの方が死亡率を下げるかもしれない https://t.co/ado4HsMdBQ
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/puilqZrWEd
Es ist besser wenn man schon ab 40 eine Mammographie macht. #medizin #onkologie #brustkrebs #screening Source. Effect of mammographic screening from age 40 years on breast cancer mortality. https://t.co/EirQjDmi8C
RT @FabienReyal: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomise…
RT @FabienReyal: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomise…
RT @FabienReyal: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomise…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/aTvswSLvXi
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial - The Lancet Oncology https://t.co/l8aDJg92iX
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/1RjIsDcoK7
RT @SkyscapeInc: Today's MedBeats: Effect of Mammographic Screening from Age 40 Years on Breast Cancer Mortality #Oncology #Hematology #Ob/…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial - The Lancet Oncology https://t.co/5oHDW7ha4E
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/s2IPnkXISj
RT @CsuIcm: Starting mammograms at 40 years increases 10 year survival. #women Start early! Effect of mammographic screening from age 40 ye…
Starting mammograms at 40 years increases 10 year survival. #women Start early! Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/Lt7mCrOIhv
RT @merino_tomas: Estudio Randomizado demuestra que mamografía desde 40 años salva vidas. A no descuidarse! @yomujer @TheLancetOncol Eff…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/a6KxYSgntf
Estudio Randomizado demuestra que mamografía desde 40 años salva vidas. A no descuidarse! @yomujer @TheLancetOncol Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. S W Duffy.
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/5N4nMqveW7 早期検診介入で予後を変えれる乳ガンがある
Effect of #mammographic #screening from age 40 years on #breastcancer #mortality (UK Age trial): final results of a randomised, controlled trial. https://t.co/6noeraJCxA
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
RT @pilarmanchon_rx: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a rando…
El reducir la edad de inicio de la pesquisa mamográfica a 40 años pudiera potencialmente reducir la mortalidad por cáncer de mama. Fuente: Duffy S W., et al. Lancet Oncol 2020 https://t.co/bLeheupPxE
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
RT @pilarmanchon_rx: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a rando…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial ▪️Mortality reduction ▪️No overdiagnosis added ▪️ Absence of increase in risk of death from other causes https://t.co/xvsKmmOva4
RT @Links_Medicus: Randomized trial: Effect of mammographic screening from age 40 years on breast cancer mortality – via @TheLancetOncol h…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial - The Lancet https://t.co/8nQcno0SuD
RT @CMalhaire: Effect of #mammographic screening from age 40 years on #breast #cancer mortality (UK Age trial): final results of a randomis…
Reducing the lower age limit for screening from 50 to 40 years could potentially reduce breast cancer mortality. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/EH6em6mNxk
RT @pnicolaubatalla: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a rando…
Effect of #mammographic screening from age 40 years on #breast #cancer mortality (UK Age trial): final results of a randomised, controlled trial - The Lancet Oncology https://t.co/oc7YxnWGE9
Randomized trial: Effect of mammographic screening from age 40 years on breast cancer mortality – via @TheLancetOncol https://t.co/5nA1mNHpLf Commentary: https://t.co/33IafRgLhg
RT @JeanSeely: 25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from ag…
Nutshell #81: #Mammography screening from the age of 40 could reduce #breastcancer death in women by 62% in a 10 year follow-up. Article: https://t.co/RKXBWf0RyB #research #medicine #science https://t.co/B5ajYFBh9L
RT @JeanSeely: 25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from ag…
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
RT @JeanSeely: 25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from ag…
RT @JeanSeely: 25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from ag…
RT @JeanSeely: 25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from ag…
RT @pnicolaubatalla: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a rando…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/XfVVrWHUQM
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/uRvINqHofQ
RT @JeanSeely: 25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from ag…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/Df25tb4i0H https://t.co/206cKlYpoA
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Study suggests mammograms in women in their 40s can save lives https://t.co/lL9uIzQCle
RT @JeanSeely: 25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from ag…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/KPfR0kH6UG
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/QxxGe2LpTy #másinvestigaciónparamásvida Ⓡ
RT @CancerPrev_KCL: Congratulations to our Shama Sheikh, Louise Johns and Peter Sasieni together with colleagues at @QMCCP Effect of mamm…
RT @womenofteal: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): https://t.co/a1oYyc4Rox #bc…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): https://t.co/a1oYyc4Rox #bcsm #gyncsm "Reducing the lower age limit for screening from 50 to 40 years could potentially reduce breast cancer mortality."
“Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial” - @TheLancetOncol - strong argument for reducing the screening age! https://t.co/LJlvjfXDsh
RT @CancerPrev_KCL: Congratulations to our Shama Sheikh, Louise Johns and Peter Sasieni together with colleagues at @QMCCP Effect of mamm…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial - The Lancet https://t.co/8nQcno0SuD
25% reduction in breast cancer mortality in 40-49yo despite using older technology. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/vRIbaJdmxt @CanadaSBI @CARadiologists
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial) https://t.co/HFP5wmaSo1
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/DVcgkBixC8
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
RT @CancerPrev_KCL: Congratulations to our Shama Sheikh, Louise Johns and Peter Sasieni together with colleagues at @QMCCP Effect of mamm…
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
RT @petersasieni: Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomis…
Congratulations to our Shama Sheikh, Louise Johns and Peter Sasieni together with colleagues at @QMCCP Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): - The Lancet Oncology https://t.co/b3LVmsFFBt
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial - The Lancet Oncology https://t.co/cUrcr1MHeW
Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/Z7XkFndPWP
Reducing the lower age limit for screening from 50 to 40 years could potentially reduce breast cancer mortality. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial https://t.co/fI5uzLP1Ey